Katelyn Obermiller
Family · Dennison, OHNPI 1639510597
Payments from drug & device makers
Across 152 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$545
- GSK$367
- AstraZeneca$304
- Amgen$192
- Novartis$182
- Novo Nordisk$168
- plus $869 from 19 others
What the payments were for
- Food & beverage$2,615100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $545 |
| GSK | 30 | $367 |
| AstraZeneca | 12 | $304 |
| Amgen | 8 | $192 |
| Novartis | 10 | $182 |
| Novo Nordisk | 8 | $168 |
| Lilly USA, LLC | 9 | $152 |
| Inspire Medical Systems, Inc. | 2 | $96 |
| Pfizer | 3 | $84 |
| Phathom Pharmaceuticals, Inc. | 5 | $78 |
| Acella Pharmaceuticals, LLC | 4 | $69 |
| Dexcom, Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Viatris Specialty LLC | 2 | $48 |
| Abbott | 2 | $34 |
| Mylan Specialty L.p. | 1 | $25 |
| Boehringer Ingelheim | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Merck | 1 | $15 |
| Bayer | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
How this compares
$2,626 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 258 | $214,097 |
| OzempicSemaglutide | 99 | $126,116 |
| MounjaroTirzepatide | 108 | $119,114 |
| EliquisApixaban | 108 | $74,780 |
| JardianceEmpagliflozin | 55 | $61,261 |
| VraylarCariprazine Hcl | 36 | $48,596 |
| TrulicityDulaglutide | 30 | $43,196 |
| Tresiba Flextouch U-200Insulin Degludec | 37 | $39,586 |
| TradjentaLinagliptin | 36 | $35,495 |
| XareltoRivaroxaban | 49 | $33,440 |
| VascepaIcosapent Ethyl | 35 | $28,223 |
| FarxigaDapagliflozin Propanediol | 21 | $25,883 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 38 | $22,930 |
| QuliptaAtogepant | 21 | $22,553 |
| Spiriva RespimatTiotropium Bromide | 28 | $17,355 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $367 | $220,142271 claims |
| Lilly USA, LLCMounjaro, Trulicity | $152 | $162,311138 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Spiriva Respimat | $24 | $137,041157 claims |
| Novo NordiskOzempic | $168 | $126,11699 claims |
| PfizerEliquis | $84 | $74,780108 claims |
| AbbVieVraylar, Qulipta, Armour Thyroid | $545 | $72,93891 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $304 | $41,63046 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $69 | $2,37448 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.
Other family in Dennison
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.